SEC EDGARAUG 201 min read$OSCR

Blackley Richard Scott sold $595K of OSCR (indirect holdings)

Blackley Richard Scott (Chief Financial Officer) sold 18,750 indirectly-held shares of Oscar Health, Inc. (OSCR) at $31.74 ($0.60M total) on 2026-08-18.

Original reporting

SEC EDGAR · Blackley Richard Scott

Published Aug 20, 2026, 8:16 PM UTC

Analysis

alphai AI DeskAI-generated

Added to alphai Aug 20, 2026, 8:51 PM UTC. Informational, not investment advice.

How this was made

alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.

About alphai AI Desk Scoring methodology Report an issue

alphai market briefInsider activity

Primary signal

$OSCR

Neutral

high confidence

Mentioned

$OSCR

Relevance

5/10

alphai data visualization · based on SEC EDGAR

Decision brief

The 30-second read

$OSCRNeutralLow

Why it matters

The transaction represents a routine insider divestiture with limited market effect.

Market read

The filing provides a factual update on insider holdings but is unlikely to drive trading activity.

What to watch

Potential upcoming earnings or strategic moves not disclosed could contextualize the sale.

Relevance 5/10Novelty 4/10Timing: filing posted on Aug 20, 2026 (post‑market)

Background

Form 4 filings disclose insider transactions; CFO sales are monitored for potential signals.

Company-level read

Ticker impact

AI estimates · verify against primary disclosures

$OSCRNeutralHigh confidence

Context

CFO Richard Scott sold 18,750 shares of Oscar Health for $595,125 via an open-market transaction.

Expected impact

No significant price impact expected.

Evidence & confidence

The sale size is modest relative to float and disclosed promptly; market typically views such CFO sales as low‑impact.

Market effects

Sector

No broader sector impact; insider sale is company‑specific.

Regional

Limited to US health‑tech investors.

Global

Minimal global relevance.

Counterpoint

What could challenge this read

Some traders may view CFO sell‑off as a bearish signal despite small size.

Key entities

Individual
Richard Scott
Chief Financial Officer of Oscar Health.
Company
Oscar Health, Inc.
US‑listed health‑tech insurer (ticker OSCR).

Read at source ← All news

AUG 24

$UNHHighAI 8/10

Health Insurer Stocks Are Soaring As Companies Get A Handle On Costs

UnitedHealth Group reported $5B in Q2 net income, with a declining medical care ratio. Shares of UnitedHealth, CVS Health, Centene, and Humana have risen significantly. Centene and Humana reported strong earnings, while Humana plans to exit some markets in 2027. Oscar Health entered new markets and saw its stock triple in six months.

forbes.com3 min

AUG 24

$OSCRHighAI 8/10

Oscar Health stock hits 52-week high at 33.54 USD

Oscar Health (OSCR) hit a 52-week high of $33.54, with a 90.7% total return over the past year. The company reported Q2 2026 adjusted earnings of $1.10 per share, beating estimates of $0.37, and revenue of $4.88 billion, exceeding expectations. InvestingPro suggests the stock may be overvalued, with a high beta of 2.39.

investing.com2 min

AUG 20

$OSCRHigh

OSCR Stock Hits 5-Year High: Oscar Sees 'Healthy Tailwinds' In 2026 On Potential Upside To Guidance

Oscar Health (OSCR) shares rose 12% to a 5-year high after the company reported strong Q1 earnings and optimistic guidance for 2026. CFO Scott Blackley cited favorable industry trends and potential upside to guidance, with membership growing 56% year-over-year to 3.17 million. The company's medical loss ratio improved to 70.5% from 75.4%. OSCR stock has gained 78% over the past year.

stocktwits.com2 min

AUG 16

$OSCRMedAI 8/10

Oscar Health (OSCR) Is Up 17.4% After Swinging To Profit And Raising 2026 Guidance - What's Changed

Oscar Health (OSCR) reported a shift to profitability in Q2 and the first half of 2026, with net income of $361.81 million in Q2 and $1.04 billion for H1. On Aug. 6, 2026, it raised 2026 guidance to $18.7–$19.0 billion revenue and $500–$700 million operating earnings. The article notes analysts may need to reassess 2029 outlooks.

simplywall.st4 min

AUG 16

$AAPLMed

Why Did AAPL, OSCR, LLY Stocks Hit 52-Week Highs Today?

Apple shares (AAPL) hit a 52-week high after the company unveiled “Siri AI” at its WWDC, with the assistant using Google Gemini tech. Oscar Health (OSCR) rose to a 52-week high after reaffirming 2026 revenue guidance of $18.7B to $19B. Eli Lilly (LLY) reached a record high on positive late-stage results for oral obesity drug Foundayo and plans to seek U.S. approval for Type 2 diabetes.

stocktwits.com4 min

AUG 10

$OSCRMed

Results: Oscar Health, Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates

Oscar Health, Inc. reported quarterly results that beat expectations, with revenue up 2.7% to $4.9b and statutory profit of $1.10, 212% above analyst forecasts. Analysts updated 2026 consensus to $18.6b revenue and EPS $1.63. The consensus price target rose 12% to $28.20.

simplywall.st5 min